The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Lilly; Roche
Consulting or Advisory Role - Novartis
Research Funding - Bristol-Myers Squibb; Novartis
Doxorubicin plus dacarbazine (DoDa), doxorubicin plus ifosfamide (DI) or doxorubicin alone (Do) as first line treatment for advanced leiomyosarcoma (LMS): A retrospective study from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG).
 
Lorenzo D'Ambrosio
No Relationships to Disclose
 
Nathan Touati
No Relationships to Disclose
 
Jean-Yves Blay
Honoraria - Bayer; GlaxoSmithKline; Lilly; Novartis; Pharmamar; Roche
Consulting or Advisory Role - Bayer; GlaxoSmithKline; Merck; Novartis; PharmaMar; Roche
Research Funding - Bayer (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pharmamar (Inst); Roche (Inst)
Other Relationship - Innate Pharma
 
Giovanni Grignani
Honoraria - Bayer; Eisai; Lilly; Novartis; Pfizer; PharmaMar
Consulting or Advisory Role - Bayer; Eisai; Lilly; Novartis; Pfizer; PharmaMar
Research Funding - Bayer; Novartis; PharmaMar
Travel, Accommodations, Expenses - PharmaMar
 
Ronan Flippot
Travel, Accommodations, Expenses - Pfizer
 
Anna Malgorzata Czarnecka
Speakers' Bureau - Bristol-Myers Squibb; MSD; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Lilly; MSD; Novartis; Pfizer; Roche
 
Sophie Piperno-Neumann
No Relationships to Disclose
 
Javier Martin Broto
Honoraria - Bayer; Lilly; Novartis; PharmaMar
Consulting or Advisory Role - PharmaMar
Research Funding - PharmaMar
Travel, Accommodations, Expenses - Lilly; PharmaMar
 
Roberta Sanfilippo
No Relationships to Disclose
 
Daniela Katz
No Relationships to Disclose
 
Florence Duffaud
Honoraria - Bayer; PharmaMar
Consulting or Advisory Role - Bayer; Lilly; Novartis; PharmaMar
Travel, Accommodations, Expenses - PharmaMar
 
Bruno Vincenzi
No Relationships to Disclose
 
Bernd Kasper
Honoraria - Bayer; Lilly; Novartis; PharmaMar
Consulting or Advisory Role - Bayer; Eisai; Lilly
Research Funding - PharmaMar
 
Daniel P. Stark
Research Funding - PharmaMar
 
Filomena Mazzeo
No Relationships to Disclose
 
Armin Tuchscherer
No Relationships to Disclose
 
Saskia Litiere
No Relationships to Disclose
 
Ward Sents
No Relationships to Disclose
 
Hans Gelderblom
Patents, Royalties, Other Intellectual Property - Amgen, Boehringer-Ingelheim, Pfizer, Novartis, Pharmamar, Daiichi, Five Prime (Inst)
Other Relationship - Daiichi Sankyo
 
Alessandro Gronchi
Honoraria - Lilly; Novartis; Pfizer; PharmaMar
Consulting or Advisory Role - Bayer; Lilly; Nanobiotix; Novartis; Pfizer; PharmaMar
Research Funding - PharmaMar (Inst)
Travel, Accommodations, Expenses - Nanobiotix; PharmaMar